Ms. Naoko Shimura and Ms. Nicola Rabson nominated for appointment as new External DirectorsMr. Shinichi Tamura, Mr. Tomohiro Tohyama and Mr.

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a biopharmaceutical company focused on cellular metabolism to treat cancer and rare genetic diseases, announced the upcoming departure of a key board member.

Holdings, Inc. (NYSE American:MTNB), a pharmaceutical company specializing in the development of drug delivery technologies with a current market capitalization of $3.08 million, announced today the ...

MALMO, SWEDEN / ACCESS Newswire / February 12, 2025 / Ascelia Pharma (STO:ACE) today announces that the Nomination Committee in preparation for the Annual General Meeting (AGM) on 7 May 2025 has been ...

Kobayashi Pharmaceutical Co. on Feb. 10 posted its first full-year profit decline since going public in 1999 as the health ...

Since expenditures are heavily skewed, the top 5 percent of patients by cost contribute a disproportionate amount to the mean ...

Glox Therapeutics has appointed of Michael Murray as chair of its board. He will work with the leadership team to accelerate ...

These populist policies are right at home in progressive circles, yet they are associated with the eclectic Cabinet nominees ...

The State Health Plan's Board of Trustees authorized staff to flesh out a proposal that would base the percentage increase of monthly premiums on employees' annual salary.

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. The ...